Efficacy of ginkgolic acids against Cryptosporidium andersoni in cell culture

Parasitology Research

Volumn 109, Issue 5, 2011, Pages 1475-1479

  Wu, Liang ^a   Jiang, Xu Gan ^a   Shen, Yu Juan ^b,c   Lu, Zhao Xi ^a   Tu, Guo Hua ^a   Fu, Xing Li ^a   Chen, Sheng Xia ^a   Cao, Jian Ping ^b,c  

^a JIANGSU UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c WHO Collaborating Centre for Malaria Schistosomiasis and Filariasis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; ANTIPROTOZOAL AGENT; ARTEMETHER; GARLICIN; GINKGOLIC ACID; NITAZOXANIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM ANDERSONI; CYTOTOXICITY TEST; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; GROWTH INHIBITION; IN VITRO STUDY; LONG TERM EXPOSURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE DEVELOPMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ALLYL COMPOUNDS; ANTIPROTOZOAL AGENTS; ARTEMISININS; CELL LINE; CELL SURVIVAL; CRYPTOSPORIDIUM; DISULFIDES; HUMANS; PARASITIC SENSITIVITY TESTS; SALICYLIC ACIDS; THIAZOLES;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM ANDERSONI;

EID: 82955249295     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-011-2433-1     Document Type: Article

References (27)

1. Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M, Kelly P (2009) High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis 9:195-201
2. Anceno AJ, Katayama H, Houpt ER, Chavalitshewinkoon-Petmitr P, Chuluun B, Shipin OV (2007) IMS-free DNA extraction for the PCR-based quantification of Cryptosporidium parvum and Giardia lamblia in surface and waste water. Int J Environ Health Res 17:297-310 (Pubitemid 47035925)
3. Cai X, Woods KM, Upton SJ, Zhu G (2005) Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro. Antimicrob Agents Chemother 49:4437-4442 (Pubitemid 41552570)
4. Chen XM, Keithly JS, Paya CV, LaRusso NF (2002) Cryptosporidiosis. N Engl J Med 346:1723-1731 (Pubitemid 34547487)
5. Chen SX, Wu L, Yang XM, Jiang XG, Li LG, Zhang RX, Xia L, Shao SH (2007) Comparative molluscicidal action of extract of Ginko biloba sarcotesta, arecoline and mclosamide on snail hosts of Schistosoma japonicum. Pestic Biochem Physiol 89:237-241 (Pubitemid 47430180)
6. Chen SX, Wu L, Jiang XG, Feng YY, Cao JP (2008) Anti-Toxoplasma gondii activity of GAS in vitro. J Ethnopharmacol 118:503-507
7. Di Giovanni GD, LeChevallier MW (2005) Quantitative-PCR assessment of Cryptosporidium parvum cell culture infection. Appl Environ Microbiol 71:1495-1500 (Pubitemid 40396688)
8. Gargala G, Delaunay A, Li X, Brasseur P, Favennec L, Ballet JJ (2000) Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells. J Antimicrob Chemother 46:57-60 (Pubitemid 30466196)
9. Guyot K, Follet-Dumoulin A, Lelievre E, Sarfati C, Rabodonirina M, Nevez G, Cailliez JC, Camus D, Dei-Cas E (2001) Molecular characterization of Cryptosporidium isolates obtained from humans in France. J Clin Microbiol 39:3472-3480 (Pubitemid 32954487)
10. Lindsay DS, Upton SJ, Owens DS, Morgan UM, Mead JR, Blagburn BL (2000) Cryptosporidium andersoni n. sp. (Apicomplexa: Cryptosporiidae) from cattle, Bos taurus. J Eukaryot Microbiol 47:91-95 (Pubitemid 30063297)
11. Liu JH, Chen XC, Zhou SC (2002) Effect of allitridin on macrophage function in mice. Journal of Taishan Medical College 23:141-142
12. Liu HP, Cao JP, Shen YJ, Chen YG, Li XH, Lu WY, Xu YX, Liu YS, Liu SX, Zhou XN, Tang LH (2007) Isolation and identification of an isolate of cow-origin Cryptosporidium sp. Chin J Parasitol Parasit Dis 25:81-86
13. Mead JR (2002) Cryptosporidiosis and the challenges of chemotherapy. Drug Resist Updat 5:47-57 (Pubitemid 34966648)
14. Michael JA, Charles RS (1987) Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J Parasitol 72:314-319
15. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63 (Pubitemid 14203433)
16. Rossignol JF (2010) Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol 124:45-53
17. Theodos CM, Griffiths JK, D'Onfro J, Fairfield A, Tzipori S (1998) Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob Agents Chemother 42:1959-1965 (Pubitemid 28363076)
18. Tony LP, Amiee D, Anis AK, Rama KK, David NB, Mark W, David TH (2001) New peroxylactones from the Jamaican sponge Plakinastrella onkodes, with inhibitory activity against the AIDS opportunistic parasitic infection Toxoplasma gondii. Tetrahedron 57:1483-1487
19. Wang J, Tanret I, Mangelings D, Fan G, Wu Y, Vander Heyden Y (2010) Fingerprint development for Ginkgo biloba extracts by pressurized capillary electrochromatography: comparison of column types. J Chromatogr Sci 48:428-435
20. Wu L, Chen SX, Jiang XG, Shen YJ, Lu ZX, Tu GH, Fu XL, Cao JP (2009) Effect of select medium supplements on in vitro development of Cryptosporidium andersoni in HCT-8 cells. Parasitol Res 105:1419-1424
21. Xiao L, Singh A, Limor J, Graczyk TK, Gradus S, Lal A (2001) Molecular characterization of Cryptosporidium oocysts in samples of raw surface water and wastewater. Appl Environ Microbiol 67:1097-1101 (Pubitemid 33643547)
22. Yang XM, Chen J, Qian ZY, Guo T (2002) Study on antibacterial of ginkgolic acids. Zhong Yao Cai 25:651-653
23. Yang XM, Qian ZY, Chen J, Zhu W, Xie JM (2004) Study on antitumor activities of ginkgolic acids from Ginkgo sarcotestas in vitro. Zhong Yao Cai 27:40-42
24. You X, Schinazi RF, Arrowood MJ, Lejkowski M, Juodawlkis AS, Mead JR (1998) In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum. J Antimicrob Chemother 41:293-296 (Pubitemid 28083137)
25. Zardi EM, Picardi A, Afeltra A (2005) Treatment of cryptosporidiosis in immunocompromised hosts. Chemotherapy 51:193-196
26. Zhao Q, Zhang M, Hong L, Zhou K, Lin Y (2010) Evaluation of drug effects on Toxoplasma gondii nuclear and plastid DNA replication using real-time PCR. Parasitol Res 106:1257-1262
27. Zhu G, Marchewka MJ, Keithly JS (1999) Cryptosporidium parvum possesses a short-type replication protein A large subunit that differs from its host. FEMS Microbiol Lett 176:367-372 (Pubitemid 29308960)